SORT-LNP
LIVE

Serial Number

99250011

Owner

ReCode Therapeutics, Inc

Attorney

Aaron D. Hendelman

Filing Date

Jun 24, 2025

Add to watchlist:

No watchlists yet
View on USPTO

SORT-LNP Trademark

Serial Number: 99250011

SORT-LNP is a trademark filed by ReCode Therapeutics, Inc on June 24, 2025. The trademark is classified under Class 5 (Pharmaceuticals), Class 41 (Education & Entertainment), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently pending registration.

Owner Contact Info

ReCode Therapeutics, Inc

1140 O’Brien Drive
Menlo Park, CA 94025

Entity Type: 03

Trademark Details

Filing Date

June 24, 2025

Registration Date

Not Registered

Published for Opposition

March 17, 2026

Goods & Services

Providing online, non-downloadable articles, books, magazines, journals, and scientific texts featuring information in the fields of genetic medicine and drug delivery

Medicines for the modification of genes and treatment of diseases, for use in the treatment of respiratory diseases, lung diseases, central nervous system diseases, immunodeficiency and autoimmune diseases, infectious diseases, liver diseases, metabolic disorders, muscular diseases, and cancer; cell and gene therapy preparations and pharmaceutical preparations with protein expression, all for the treatment of respiratory diseases, lung diseases, central nervous system diseases, immunodeficiency and autoimmune diseases, infectious diseases, liver diseases, metabolic disorders, muscular diseases, and cancer; drug carriers for medical use, namely, delivery agents in the form of non-viral lipid nanoparticles for delivering drugs to human organs

Scientific and biotechnology research and analysis in the fields of cell and gene therapy and drug delivery; research and development of medicines and drug delivery platforms for the treatment of diseases; providing scientific research and medical research information in the fields of genetic medicine and drug delivery

Providing medical information in the fields of genetic medicine and drug delivery

Filing History

NOA E-MAILED - SOU REQUIRED FROM APPLICANT
May 12, 2026 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Mar 17, 2026 NPUB
PUBLISHED FOR OPPOSITION
Mar 17, 2026 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Mar 11, 2026 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Feb 23, 2026 CNSA
EXAMINER'S AMENDMENT ENTERED
Feb 23, 2026 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Feb 23, 2026 GNEN
EXAMINERS AMENDMENT E-MAILED
Feb 23, 2026 GNEA
EXAMINERS AMENDMENT -WRITTEN
Feb 23, 2026 CNEA
PREVIOUS ALLOWANCE COUNT WITHDRAWN
Feb 9, 2026 ZZZX
WITHDRAWN FROM PUB - OG REVIEW QUERY
Dec 2, 2025 PBCR
APPROVED FOR PUB - PRINCIPAL REGISTER
Nov 12, 2025 CNSA
ASSIGNED TO EXAMINER
Nov 12, 2025 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Nov 3, 2025 NWOS
APPLICATION FILING RECEIPT MAILED
Jun 24, 2025 MAFR
NEW APPLICATION ENTERED
Jun 24, 2025 NWAP